AEPCX
Price
$59.44
Change
+$0.30 (+0.51%)
Updated
Sep 5 closing price
Net Assets
133.49B
SGQCX
Price
$42.18
Change
+$0.17 (+0.40%)
Updated
Sep 5 closing price
Net Assets
474.05M
Interact to see
Advertisement

AEPCX vs SGQCX

Header iconAEPCX vs SGQCX Comparison
Open Charts AEPCX vs SGQCXBanner chart's image
American Funds EUPAC C
Price$59.44
Change+$0.30 (+0.51%)
VolumeN/A
Net Assets133.49B
DWS International Growth C
Price$42.18
Change+$0.17 (+0.40%)
VolumeN/A
Net Assets474.05M
AEPCX vs SGQCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPCX vs. SGQCX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and SGQCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. SGQCX (474M). SGQCX pays higher dividends than AEPCX: SGQCX (0.39) vs AEPCX (0.16). AEPCX was incepted earlier than SGQCX: AEPCX (25 years) vs SGQCX (24 years). SGQCX (2.17) is less costly to investors than AEPCX (1.57). AEPCX is a more actively managed with annual turnover of: 35.00 vs. SGQCX (7.00). AEPCX has a lower initial minimum investment than SGQCX: AEPCX (250) vs SGQCX (1000). SGQCX annual gain was more profitable for investors over the last year : 10.74 vs. AEPCX (7.59). SGQCX return over 5 years is better than : 14.23 vs. AEPCX (7.78).
AEPCXSGQCXAEPCX / SGQCX
Total Expense Ratio1.571.8784%
Annual Report Gross Expense Ratio1.572.1772%
Fund Existence25 years24 years-
Gain YTD15.03815.21499%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets133B474M28,059%
Annual Yield % from dividends0.160.3942%
Returns for 1 year7.5910.7471%
Returns for 3 years32.6538.4885%
Returns for 5 years7.7814.2355%
Returns for 10 years34.3459.0458%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.270.03
+2.42%
Pacific Biosciences of California
VVX56.681.23
+2.22%
V2X
GANX1.760.02
+1.15%
Gain Therapeutics
LINE40.590.13
+0.32%
Lineage Inc.
QVCGP6.980.02
+0.29%
QVC Group Inc.